Some patients with gastro-oesophageal reflux disease have delayed gastric emptying. This study investigates the effect of cisapride on gastric emptying in 34 patients with proved reflux and delayed gastric emptying of solids.
emptying. The protocol was repeated with the crossover tablet. Gastric, emptying was assessed by a dual radionucide technique. The percentage of a solid meal remaining in the stomach at 100 minutes (% R,. minutes) and the time taken for 50% of the liquid to empty (T,. minutes) were calculated and analysed by the Wilcoxon matched pairs signed ranks test and expressed as medians (ranges). For gastric emptying of solids the initial % R,. minutes (70 (60-100)%) was not sigaificantly different from placebo (71 (35-100)%). After cisapride treatment a significant acceleration (p<0001) in gastric emptying occurred (% R,. minutes, 505 (28-93)%). Similarly with gastric emptying of liquids, the initial T,. minute value was 26.5 (12-82) minutes, after placebo the value was 28 (11-81) minutes, but this was significantly accelerated with cisapride (p<0.03) to 22*5 (6- 61) minutes. The acceleration in gastric emptying occurred in the proximal portion of the stomach for gastric emptying ofboth solids and liquids suggesting that this is the principal site of action of cisapride. We conclude that cisapride significantly accelerates gastric emptying of both solids and liquids in patients with gastro-oesophageal reflux disease and delayed gastric emptying.
It is now established that some patients with gastro-oesophageal reflux disease have delayed gastric emptying of liquids or solids, or both. The relative proportions ofpatients with delayed emptying, however, and the importance of any delay remain controversial.' Because gastric emptying is a complex process and many factors influence it, some of the differences that have been recorded are probably related to the different assessment techniques being used.
Cisapride is a prokinetic agent that has been shown to enhance gastric emptying in normal patients2 and in those with dyspepsia.3 The aim of this study was to assess the effect of cisapride on gastric emptying in patients with delayed gastric emptying and gastro-oesophageal reflux disease.
Methods

PATIENTS
The subjects were patients referred to our unit for the investigation of symptoms of gastrooesophageal reflux disease. Thirty four patients were enrolled in the trial. There were equal numbers of men and women (median age 51 years, range 18-81 years). Three of the patients had undergone previous gastro-oesophageal surgery but none was taking any medication known to alter gastric emptying or acid production. All patients entered in the study had been shown to have delayed solid gastric emptying according to criteria previously published4 -21 patients had delay in solid emptying alone and 13 For the solid component of the meal these were the lag period before food left the stomach, the percentage remaining at 100 minutes (% R,.8 minutes), and the linear emptying after the lag period. The 50% emptying time for the solid meal was not used because some patients did not reach 50% emptying during the study period of two hours. For the liquid component the time for 50% emptying (T50 minutes) was obtained.
In 27 ofthe studies, analysis ofthe distribution of the meal within the stomach was undertaken.7 This was performed by dividing the gastric region into proximal and distal regions of interest. The proximal stomach was defined as that part which was filled by the initial solid meal bolus at the end of the meal. The region defined by this bolus was designated the proximal stomach and the remaining area the distal stomach.
From analysis of the proximal and distal regions of interest it was possible to determine the percentage of solid remaining in the proximal stomach at 55 minutes (% R,, minutes), and the time taken until 90% of the maximum distal stomach counts were reached (DTj). A measure of retention in the distal stomach was derived by subtracting the DT,0 value from the total stomach lag period.7 Proximal gastric liquid emptying was measured by taking the percentage of the liquid meal remaining in the proximal stomach at 20 minutes (% R20 minutes), and an identical set of measures to those used for solid emptying were taken for distal gastric retention of liquid (a liquid DT8o and liquid lag-DTj).
SYMPTOMS
Symptoms were recorded at the time of enrolment into the study using a symptom score to 10 showed no evidence of oesophagitis, seven showed mild, five moderate, and eight severe oesophagitis. GASTRIC 
EMPTYING
The % R,., minutes solid meal emptying values were not significantly different between the pretreatment and placebo studies (Fig 1) . These values were significantly less, however, in the cisapride treated group compared with either the placebo or the pretreatment groups (p<00003, p<0O0002 respectively) (Figs 2 and 3 ). There were also significantly shorter lag periods (p<0001) for the cisapride group compared with the pretreatment or placebo groups (Table) . Similarly, the rates of solid emptying after the lag period were more rapid (p<0001) in the cisapride group. The liquid emptying results showed a similar pattern (Figs 1, 2, and 3) .
In three patients the proximal stomach region was not clearly enough defined to allow delineation of a proximal and distal region of interest. Furthermore, as a result of misadventure in transferring data several other studies were lost after carrying out total emptying analysis. The gastric regions ofinterest were suitably defined to allow distributional analysis in 27 ofthe solid and liquid gastric emptying studies.
Gastric emptying times from the proximal stomach for solids, determined by the % R,, minutes values, were significantly less in the cisapride group than in the pretrial (p<00003) and placebo groups (p<002) (Fig 4) . The DT90
values were also reduced in the cisapride group compared with placebo (p<003) and pretreatment (p<0002) results (Fig 5) . The genetic role in the development of reflux disease.617
Furthermore, it has been found that the delay in solid emptying in patients with reflux disease occurs in the proximal rather than in the distal stomach.'8 Morphological abnormalities have been described in both the antrum and body of the stomach in patients with reflux disease.'92' The retention of food in the proximal stomach introduces the potential for a greater number of transient lower oesophageal sphincter relaxations to occur. 22 An increase in the number of these transient sphincter relaxations in patients with reflux disease has been reported,23 but it has not been correlated with gastric emptying.
Cisapride is a drug that has been shown to enhance gastric emptying of both solids and liquids in normal subjects and patients with dyspepsia. Its effect on gastric emptying in patients with gastro-oesophageal reflux disease and delayed emptying has not been reported, and it was the aim ofthis study to examine cisapride's effects in these patients. We,have found previously that symptoms ofgastro-oesophageal reflux disease are improved by the gastric prokinetic agents, metaclopramide and domperidone, but the improvement in symptoms was not significantly different from that obtained with placebo.24 Cisapride has been reported to accelerate gastric emptying in patients with dyspepsia,3 although another group reported no such effect. 25 Our study shows that in patients with gastrooesophageal reflux disease and delayed solid gastric emptying, three days of low dose cisapride (10 mg, three times a day) caused a significant acceleration in total gastric emptying of solids and liquids. In the case of the solid meal this acceleration was associated with a significant shortening of the redistribution time within the stomach, as measured by the time of retention in the proximal stomach and the time taken for the meal to move into the distal stomach. Cisapride could effect these changes either by enhancing proximal gastric motor activity or by decreasing distal gastric retropulsion of food. Either or both ofthese mechanisms could have led to the results we obtained in these patients. Retropulsion was not observed, however, and so it seems more likely that cisapride had its effect on the proximal stomach.
On the other hand, the distal stomach does not seem to be emptying more rapidly once the bolus offood is delivered to it. If cisapride has led to an alteration in antral capacity, we are unsure how this would have affected our measurements. It could have led to an acceleration in gastric emptying but presumably would not have altered the redistribution time. Thus it seems more likely that the action of cisapride is on the proximal rather than the distal stomach in patients with gastro-oesophageal reflux and delayed gastric emptying.
It is of interest that the regulation of solid emptying from the stomach is often ascribed mainly to the antrum, although emptying is undoubtedly a complex process. 26 Our results support the concept that the fundus and body of the stomach may play a more fundamental role in emptying of solids than is usually acknowledged.7 As was expected, both placebo and cisapride led to amelioration in patients' symptoms. 24 Because of the short time course of treatment, however, symptomatic outcome was not a major aim of this study.
These results provide encouragement for further studies to determine if prolonged administration of cisapride to patients with gastro-oesophageal reflux disease and delayed gastric emptying will have a beneficial effect on the course of the disease.
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